25 September 2017

Amedeo Smart

Independent Medical Education

Subscriber: th..@boehringer-ingelheim.com

HIV Infection

25 September 2017 | n=37

  1. Jao J, Powis KM, Kirmse B, Yu C, et al.
    Lower mitochondrial DNA and altered mitochondrial fuel metabolism in hiv-exposed uninfected infants in cameroon.
    AIDS 2017.

  2. Besson C, Lancar R, Prevot S, Algarte-Genin M, et al.
    Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern cART era.
    AIDS 2017.

  3. Ewing AC, King CC, Wiener JB, Chasela CS, et al.
    Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
    AIDS 2017.

  4. Scheepers C, Chowdhury S, Wright WS, Campbell CT, et al.
    Serum glycan-binding IgG antibodies in HIV-1 infection and during the development of broadly neutralizing responses.
    AIDS 2017.

  5. Angelovich TA, Hearps AC, Oda MN, Borja MS, et al.
    Dysfunctional HDL from HIV+ individuals promotes monocyte-derived foam cell formation in vitro.
    AIDS 2017.

  6. van Heukelom MLS, Marra E, de Vries HJC, van der Loeff MFS, et al.
    Risk factors for anal HSIL in HIV-positive MSM: is targeted screening possible?
    AIDS 2017.

  7. Chow FC, Regan S, Zanni MV, Looby SE, et al.
    Elevated ischemic stroke risk among women living with HIV infection.
    AIDS 2017.

  8. Lake JE, Li X, Palella FJ Jr, Erlandson KM, et al.
    Metabolic health across the body mass index spectrum in HIV-Infected and HIV-Uninfected Men.
    AIDS 2017.

  9. Rodriguez-Hart C, Nowak RG, Musci R, German D, et al.
    Pathways from sexual stigma to incident HIV and sexually transmitted infections among Nigerian men who have sex with men.
    AIDS 2017.

  10. Duquenne C, Gimenez S, Guigues A, Viala B, et al.
    Reversing HIV latency via sphingosine-1-phosphate receptor 1 signaling.
    AIDS 2017.

  11. Thornton AC, Jose S, Bhagani S, Chadwick D, et al.
    Hepatitis B, hepatitis C and mortality among HIV-positive individuals.
    AIDS 2017.

  12. Mikulak J, Oriolo F, Zaghi E, Di Vito C, et al.
    Natural Killer cells in HIV-1 infection and therapy.
    AIDS 2017.

  13. Kuniholm MH, Liang H, Anastos K, Gustafson D, et al.
    Association of a 3' Untranslated Region Polymorphism in PCSK9 with HIV Viral Load and CD4+ Levels in HIV/Hepatitis C Virus Co-Infected Women.
    AIDS 2017.

  14. Balasubramanian R, Fowler MG, Dominguez K, Lockman S, et al.
    Time to first positive HIV-1 DNA PCR may differ with antiretroviral regimen in infants infected with non-B subtype HIV-1.
    AIDS 2017.

  15. Merriam DP, Chen C, Mendez-Lagares G, Rogers K, et al.
    Depletion of gut-resident CCR5+ cells for HIV cure strategies.
    AIDS Res Hum Retroviruses 2017.

  16. Shuper PA, Joharchi N, Monti PM, Loutfy M, et al.
    Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment.
    J Acquir Immune Defic Syndr 2017.

  17. Grebe E, Welte A, Hall J, Keating SM, et al.
    Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms.
    J Acquir Immune Defic Syndr 2017.

  18. Prendergast AJ, Chasekwa B, Rukobo S, Govha M, et al.
    Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants.
    J Infect Dis 2017;216:651-661.

  19. Foldi J, Kozhaya L, McCarty B, Mwamzuka M, et al.
    HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions.
    J Infect Dis 2017;216:641-650.

  20. Rockwood N, Sirgel F, Streicher E, Warren R, et al.
    Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
    J Infect Dis 2017;216:632-640.

  21. Kooij KW, Vogt L, Wit FWNM, van der Valk M, et al.
    Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    J Infect Dis 2017;216:622-631.

  22. de Pokomandy A, Kaufman E, de Castro C, Mayrand MH, et al.
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis 2017;216:447-456.

  23. Smith B.
    Toward Understanding the When and Why of Human Immunodeficiency Virus-Associated Stroke.
    J Infect Dis 2017;216:509-510.

  24. Benjamin LA, Allain TJ, Mzinganjira H, Connor MD, et al.
    The Role of Human Immunodeficiency Virus-Associated Vasculopathy in the Etiology of Stroke.
    J Infect Dis 2017;216:545-553.

  25. Mollan KR, Tierney C, Hellwege JN, Eron JJ, et al.
    Race/Ethnicity and the Pharmacogenetics of Reported Suicidality With Efavirenz Among Clinical Trials Participants.
    J Infect Dis 2017;216:554-564.

  26. Fauteux-Daniel S, Larouche A, Calderon V, Boulais J, et al.
    Vertical transmission of hepatitis C virus: variable transmission bottleneck and evidence of mid-gestation in utero infection.
    J Virol 2017.

  27. Galvis AE, Fisher HE, Fan H, Camerini D, et al.
    Conformational Changes in the 5' End of the HIV-1 Genome Dependent on the Debranching Enzyme DBR1 During Early Stages of Infection.
    J Virol 2017.

  28. Valle-Casuso JC, Allouch A, David A, Lenzi GM, et al.
    p21 restricts HIV-1 in monocyte-derived dendritic cells through the reduction of dNTP biosynthesis and regulation of SAMHD1 antiviral activity.
    J Virol 2017.

  29. Contreras-Galindo RA, Dube D, Fujinaga K, Kaplan MH, et al.
    Susceptibility of Human Endogenous Retrovirus Type-K to Reverse Transcriptase Inhibitors.
    J Virol 2017.

  30. Rife Magalis B, Nolan DJ, Autissier P, Burdo TH, et al.
    Insights into the impact of CD8+ immune modulation on HIV evolutionary dynamics in distinct anatomical compartments using SIV-infected macaque models of AIDS progression.
    J Virol 2017.

  31. Brocca-Cofano E, Kuhrt D, Siewe B, Xu C, et al.
    Pathogenic Correlates of the Simian Immunodeficiency Virus (SIV)-Associated B Cell Dysfunction.
    J Virol 2017.

  32. .
    Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet 2017;390:1151-1210.

  33. .
    Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet 2017;390:1084-1150.

  34. Xu L, Pegu A, Rao E, Doria-Rose N, et al.
    Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques.
    Science 2017.

  35. Jia M, Shaw T, Zhang X, Liu D, et al.
    Decoding noises in HIV computational genotyping.
    Virology 2017;511:249-255.

  36. Sadeghirad B, Siemieniuk RAC, Brignardello-Petersen R, Papola D, et al.
    Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials.
    BMJ 2017;358:j3887.

  37. Aertgeerts B, Agoritsas T, Siemieniuk RAC, Burgers J, et al.
    Corticosteroids for sore throat: a clinical practice guideline.
    BMJ 2017;358:j4090.

Display articles in

Amedeo HIV Infection

Data Origin

You selected the following journals for your Amedeo HIV Infection newsletter:

AIDS, AIDS Res Hum Retroviruses, Ann Intern Med, BMJ, Clin Infect Dis, J Acquir Immune Defic Syndr, J Clin Immunol, J Clin Invest, J Infect Dis, J Med Virol, J Virol, JAMA, Lancet, N Engl J Med, Nat Med, Pediatr Infect Dis J, Science, Virology.

To modify the journal selection, please open your Newsletter Management Page. If you don't remember the URL, please submit the email address of your Amedeo subscription.

Your email:

Amedeo HIV Infection

Five-Week Literature

16 July 2018

09 July 2018

02 July 2018

25 June 2018

18 June 2018

25 September 2017

Multidisciplinary Journal Club

  1. Xie YL, Chakravorty S, Armstrong DT, Hall SL, et al.
    Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
    N Engl J Med. 2017;377:1043-1054.

  2. Wolchok JD, Chiarion-Sileni V, Gonzalez R, Rutkowski P, et al.
    Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
    N Engl J Med. 2017 Sep 11. doi: 10.1056/NEJMoa1709684.

  3. Weber J, Mandala M, Del Vecchio M, Gogas HJ, et al.
    Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma.
    N Engl J Med. 2017 Sep 10. doi: 10.1056/NEJMoa1709030.

Every week, Amedeo's Multidisciplinary Journal Club (MJC) presents a selection of outstanding articles. Take a look beyond the horizon.

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016